Arteriovenous Shunt, Surgical/adverse effects; Blood Vessel Prosthesis Implantation/adverse effects; Blood Vessel Prosthesis/adverse effects; Catheter-Related Infections/epidemiology; Catheterization, Central Venous/adverse effects; Central Venous Catheters/adverse effects; Prosthesis-Related Infections/epidemiology; Renal Dialysis/adverse effects; Staphylococcal Infections/epidemiology; Administration, Intravenous; Ambulatory Care; Anti-Infective Agents/administration & dosage; Arteriovenous Shunt, Surgical/instrumentation; Bacteremia/epidemiology; Bacteremia/microbiology; Blood Vessel Prosthesis Implantation/instrumentation; Catheter-Related Infections/diagnosis; Catheter-Related Infections/drug therapy; Catheter-Related Infections/microbiology; Catheterization, Central Venous/instrumentation; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus/isolation & purification; Population Surveillance; Prognosis; Prosthesis-Related Infections/diagnosis; Prosthesis-Related Infections/drug therapy; Prosthesis-Related Infections/microbiology; Quality Indicators, Health Care; Risk Factors; Staphylococcal Infections/diagnosis; Staphylococcal Infections/drug therapy; Staphylococcal Infections/microbiology; Time Factors; United States/epidemiology

dialysis; infection; surveillance